» Articles » PMID: 14646336

Platelet-activating Factor Concentration in the Stool of Human Newborns: Effects of Enteral Feeding and Neonatal Necrotizing Enterocolitis

Overview
Journal Biol Neonate
Date 2003 Dec 3
PMID 14646336
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Epidemiologic studies have identified enteral feedings as a risk factor for necrotizing enterocolitis (NEC). Enteral feedings provide the substrate for colonization of the newborn gut with gram-negative bacteria with endotoxin production, which may trigger the production of endogenous inflammatory mediators, including platelet-activating factor (PAF). In this prospective study, we examined the effect of enteral feeding on PAF concentration in the stool of preterm and full-term human newborns. The concentration of PAF levels in stool was measured at the following times: at passage of first meconium, within 24 h prior to the onset of feedings, at the 3rd and 14th day of feeding and at any time confirmed NEC developed. Stool samples also were analyzed for levels of acetylhydrolase, the PAF breakdown enzyme. Stool PAF concentration rose significantly following the start of enteral feedings. The mean PAF concentration for day 14 samples was significantly higher than the mean concentration of meconium samples (4.90 +/- 1.03 vs. 1.81 +/- 0.38 ng/g, p < 0.05) and day 0 samples (4.90 +/- 1.03 vs. 1.79 +/- 0.39 ng/g, p < 0.05). For the 7 patients diagnosed with definite NEC, the mean stool PAF concentration was 12.42 +/- 0.77 ng/g, significantly elevated compared to the mean PAF levels in stool from healthy infants at all sampling times (p < 0.01). There was no significant change in acetylhydrolase activity at any of the sampling times. Stool PAF concentration increases with the provision of enteral feedings and rises further with the development of NEC. Since stool acetylhydrolase activity remained unchanged, we speculate the increase of PAF in stool likely represents increased PAF production at the local level following the provision of enteral feedings or the development of neonatal necrotizing enterocolitis.

Citing Articles

The Microbiome and Biomarkers for Necrotizing Enterocolitis: Are We Any Closer to Prediction?.

Rusconi B, Good M, Warner B J Pediatr. 2017; 189:40-47.e2.

PMID: 28669607 PMC: 5614810. DOI: 10.1016/j.jpeds.2017.05.075.


The Role of Mucosal Immunity in the Pathogenesis of Necrotizing Enterocolitis.

Hodzic Z, Bolock A, Good M Front Pediatr. 2017; 5:40.

PMID: 28316967 PMC: 5334327. DOI: 10.3389/fped.2017.00040.


The immunological landscape in necrotising enterocolitis.

Cho S, Berger P, Nold-Petry C, Nold M Expert Rev Mol Med. 2016; 18:e12.

PMID: 27341512 PMC: 5001507. DOI: 10.1017/erm.2016.13.


Surfactant protein-D attenuates the lipopolysaccharide-induced inflammation in human intestinal cells overexpressing toll-like receptor 4.

Saka R, Wakimoto T, Nishiumi F, Sasaki T, Nose S, Fukuzawa M Pediatr Surg Int. 2015; 32(1):59-63.

PMID: 26510735 DOI: 10.1007/s00383-015-3812-y.


Pathogenesis of neonatal necrotizing enterocolitis.

Lim J, Golden J, Ford H Pediatr Surg Int. 2015; 31(6):509-18.

PMID: 25854935 DOI: 10.1007/s00383-015-3697-9.